Prices, availability, and affordability of adult medicines in 54 low-income and middle-income countries: evidence based on a secondary analysis

This publication has 14 references indexed in Scilit:

• Availability, pricing and affordability of essential medicines in Eastern Ethiopia: a comprehensive analysis using WHO/HAI methodology
  Journal of Pharmaceutical Policy and Practice, 2021
• Essential medicine shortages, procurement process and supplier response: A normative study across Indian states
  Social Science & Medicine, 2021
• Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study
  The Lancet Diabetes & Endocrinology, 2018
• Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data
  The Lancet Public Health, 2017
• Do changes to supply chains and procurement processes yield cost savings and improve availability of pharmaceuticals, vaccines or health products? A systematic review of evidence from low-income and middle-income countries
  BMJ Global Health, 2017
• Policies to promote use of generic medicines in low and middle income countries: A review of published literature, 2000–2010
  Health Policy, 2012
• Switching from Originator Brand Medicines to Generic Equivalents in Selected Developing Countries: How Much Could Be Saved?
  Value in Health, 2012
• The expanding world market of generic pharmaceuticals
  Journal of Generic Medicines, 2011
• Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis
  The Lancet, 2009
• Barriers to healthcare as reported by rural and urban interprofessional providers
  Journal of Interprofessional Care, 2006